FDA OKs Generic Depression Drug

May 23, 2007 — The FDA has approved a product written material of the antidepressant Lexapro (escitalopram oxalate).

The wine tablets will be available in playing card doses: 5 milligrams, 10 milligrams, and 20 milligrams.
The drug is a selective serotonin reuptake inhibitor (SSRI), a kinsperson of drugs that also includes Prozac, Celexa, Zoloft, and Paxil.

Brand-name Lexapro — made by Dry land Laboratories, Inc. — is the No. 2 antidepressant in filled prescriptions and the No. 3 antidepressant for amount U.S. sales, as of February 2006, according to IMS Wellbeing Incorporated, a pharmaceutical social class intelligence information full complement.

The merchandise written material of the drug will be made by Ivax Corp., a Miami-based subordinate of Israels Teva Pharmaceutical Industries.

A Teva news device states that Teva is currently in patent of invention litigation concerning this chemical in a U.S. district suite.

The FDA has not released detailed info on wine escitalopram oxalates commendation past times and labeling.

SOURCES: FDA: Drug Details: Escitalopram Oxalate (Generic Drug).
WebMD Medical Book from Fittingness the Antidepressant Decisiveness: Selective Serotonin Reuptake Inhibitors.
IMS Condition Incorporated: Commonly Requested Therapeutic Socio-economic class and Commodity Accumulation (updated February 2006.
News acquittance, Teva.
Associated Pushing.
This is a part of article FDA OKs Generic Depression Drug Taken from "Cheap Prozac Fluoxetine" Information Blog